Infertility News and Research

RSS

Infertility primarily refers to the biological inability of a person to contribute to conception. Infertility may also refer to the state of a woman who is unable to carry a pregnancy to full term.

More hormone treatments decrease women's chances of having baby

A Michigan State University study has found that too much of a hormone commonly used during in vitro fertility, or IVF, treatments actually decreases a woman's chances of having a baby.

24 Nov 2015

Roundworm infection increases fertility among women in the Amazon

Parasitic worms can live inside humans gaining nourishment from the food we ingest (roundworms) or from our blood (hook worms), whilst being safe from predators. Although roundworm infections are generally symptomless they are not something any of us would choose to have. However, it has recently been found that infection with roundworm increases a woman's fertility.

20 Nov 2015

Women & Infants Hospital recognized as 2014 Top Performer on Key Quality Measures

Women & Infants Hospital of Rhode Island, a Care New England hospital, announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures by The Joint Commission, the leading accreditor of health care organizations in the U.S.

19 Nov 2015

Changes in cellular metabolites regulate earliest stages of embryonic stem cell development

Changes in cellular metabolites have been shown to regulate embryonic stem cell development at the earliest stages of life. Metabolites are simple compounds generated during life-sustaining chemical activities in cells.

17 Nov 2015

FEC recognizes Rachel S. Weinerman for receiving 2015 Scientific Program Prize Paper Award

The Foundation for Embryonic Competence is pleased to recognize Dr. Rachel S. Weinerman, a clinical assistant professor, reproductive endocrinology and infertility at University Hospitals Case Medical in Cleveland, for receiving the 2015 Scientific Program Prize Paper Award at the 71st Annual American Society for Reproductive Medicine conference in Baltimore, Maryland on October 21, 2015.

12 Nov 2015

New Swedish study questions treatment of female infertility with stem cell therapy

It has been claimed that a treatment for female infertility will be available by stem cell therapy. But a new study by Swedish researchers from the University of Gothenburg and Karolinska Institutet published in Nature Medicine questions whether new egg cells can be produced using stem cells.

4 Nov 2015

INVO Bioscience obtains de novo clearance from FDA for INVOcell fertility treatment

INVO Bioscience, Inc., a medical device company focused on treatment option for patients diagnosed with infertility, today announced that the U.S. Food and Drug Administration has granted the Company's de novo request for the INVOcell.

4 Nov 2015

Researchers develop biochemical trick that can extend lifespan of peptides

Researchers at University of the Pacific have developed a biochemical trick that can significantly extend the lifespan of peptides, smaller cousins of proteins. The finding opens up new possibilities for creating peptides to treat cancer, infertility and other conditions.

3 Nov 2015

UAB study aims to provide improved care related to reproductive health of women with CF

For University of Alabama at Birmingham School of Nursing Assistant Professor Sigrid Ladores, Ph.D., investigating reproductive health concerns in adolescents and young adults with chronic illnesses, particularly those with cystic fibrosis, is not just a profession, it is a passion.

3 Nov 2015

Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 National Cancer Research Institute Cancer Conference today (Tuesday).

3 Nov 2015

New paper device could rapidly and inexpensively assess hepatitis B, male infertility

Scientists have developed a new paper device that analyzes DNA and could rapidly and inexpensively assess disparate conditions including hepatitis B and male infertility, which together affect millions of people around the world. The test, reported in the Journal of the American Chemical Society, could be of particular help diagnosing people in low-income areas.

29 Oct 2015

Study shows restoring testosterone production in men does not impact their fertility

Restoring testosterone production in men may be as effective as replacing it, without compromising their fertility. Two phase III clinical trials show that a drug that restores the body’s natural production of testosterone has no negative effect on a man’s sperm count while a topical testosterone gel causes a significant drop.

28 Oct 2015

Juneau Biosciences presents new genetic discoveries in endometriosis at annual ASRM meeting

This week, Juneau Biosciences, LLC presented new discoveries concerning the genetics of endometriosis at the annual American Society of Reproductive Medicine (ASRM) meeting in Baltimore, MD.

23 Oct 2015

CCRM Network partners with ACRM to provide outstanding patient care in the southeastern U.S.

The CCRM Network, a leading infertility treatment network, is excited to announce it has entered into partnership with the Atlanta Center for Reproductive Medicine. This partnership will provide patients in the southeastern U.S. with continued access to ACRM's outstanding patient care and outcomes, as well as leading fertility technology developed by the CCRM Network.

15 Oct 2015

ARC Telehealth System allows fertility patients connect with medical professionals through mobile devices

ARC Fertility today announced its Telehealth System, designed to help fertility patients connect with medical professionals via mobile devices to improve communication, speed treatment and increase quality of care.

15 Oct 2015

Aspen Park Pharmaceuticals acquires worldwide rights to APP-111 therapy from Ohio State University

Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).

30 Sep 2015

Cancer treatment does not affect pregnancy outcome, shows new study

Women who are pregnant when diagnosed with cancer can start treatment for their disease immediately and do not need to terminate their pregnancy due to worries over the effects of therapy on the development of their child.

29 Sep 2015

Endocrine-disrupting chemical exposure linked to increased risk of diabetes and obesity

Emerging evidence ties endocrine-disrupting chemical exposure to two of the biggest public health threats facing society - diabetes and obesity, according to the executive summary of an upcoming Scientific Statement issued today by the Endocrine Society.

29 Sep 2015

Hormonal therapy may protect women's ovaries, increase chances of pregnancy after breast cancer treatment

Young women undergoing chemotherapy for breast cancer may be more likely to remain fertile if they also receive hormonal treatment, according to new research presented to the 2015 European Cancer Congress on Monday and published simultaneously in Annals of Oncology.

28 Sep 2015

Standard clomiphene treatment better than proposed alternative for unexplained fertility

It is estimated that approximately 10 percent of women of child-bearing age may be unable to get pregnant or to carry a pregnancy to term.

26 Sep 2015

Infertility News and Research

Further Reading

More hormone treatments decrease women's chances of having baby

Roundworm infection increases fertility among women in the Amazon

Women & Infants Hospital recognized as 2014 Top Performer on Key Quality Measures

Changes in cellular metabolites regulate earliest stages of embryonic stem cell development

FEC recognizes Rachel S. Weinerman for receiving 2015 Scientific Program Prize Paper Award

New Swedish study questions treatment of female infertility with stem cell therapy

INVO Bioscience obtains de novo clearance from FDA for INVOcell fertility treatment

Researchers develop biochemical trick that can extend lifespan of peptides

UAB study aims to provide improved care related to reproductive health of women with CF

Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

New paper device could rapidly and inexpensively assess hepatitis B, male infertility

Study shows restoring testosterone production in men does not impact their fertility

Juneau Biosciences presents new genetic discoveries in endometriosis at annual ASRM meeting

CCRM Network partners with ACRM to provide outstanding patient care in the southeastern U.S.

ARC Telehealth System allows fertility patients connect with medical professionals through mobile devices

Aspen Park Pharmaceuticals acquires worldwide rights to APP-111 therapy from Ohio State University

Cancer treatment does not affect pregnancy outcome, shows new study

Endocrine-disrupting chemical exposure linked to increased risk of diabetes and obesity

Hormonal therapy may protect women's ovaries, increase chances of pregnancy after breast cancer treatment

Standard clomiphene treatment better than proposed alternative for unexplained fertility

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News